The British Medical Association held a meeting on 25 February to agree actions required to tackle prescribed drug dependence, covering benzodiazepines, z-drugs, antidepressants and opiate painkillers. This follows the BMA’s request for evidence on this issue in 2014, which led to the publication of their analysis report last year. The meeting was chaired by Baroness Hollins and included […]
Tag Archives | BMA
CEP welcomes report by the BMA on prescribed drug dependence
The Council for Evidence-based Psychiatry welcomes the publication of the analysis report by the BMA’s Board of Science, titled ‘Prescribed drugs associated with dependence and withdrawal – building a consensus for action’, which can be viewed here. The report analyses evidence submissions from a variety of stakeholders, including CEP, patient groups and medical bodies such as the […]
Part Two of CEP survey for BMA launched – your input needed
Due to the considerable response to our survey on prescribed drug issues we have decided to launch Part Two in order to provide improved summaries of the results to the BMA. Part One of this survey is ‘qualitative’ and your answers are provided using words and sentences. This enables CEP and the BMA to review […]
SURVEY – CEP needs your contribution for BMA review into prescribed drugs
The Council for Evidence-based Psychiatry (cepuk.org) has been invited to contribute evidence to a project at the BMA (British Medical Association) which will review the issues associated with dependence upon prescribed drugs, including benzodiazepines, sleeping pills, pain relievers and antidepressants. If you or a family member has experienced negative effects with one or more of […]